Remove Cannabinoids Remove Events Remove Extraction
article thumbnail

Review: Blue Agave Live Badder by Bullet Train Extracts

Illinois News Joint

s brand Bullet Train Extracts. This batch of live badder picked up at Trinity Compassionate Care tested at 82.05% THCa, 3.26% Delta-9-THC, 0.19% CBDa, and 89.59% total cannabinoids. To learn more about cannabis-friendly events in Illinois, visit here. Terpenes were labeled as 72,090.01 ug/g which calculates to 7.2%

article thumbnail

Germany’s Legalization Plans, Dyrdek and Diplo’s Cannabis Seltzers, and Oregon’s Synthetic Cannabinoid Ban

Veriheal

Oregon Bans Synthetic Cannabinoids. Beginning next month, Oregon’s ban on the sale of synthetic cannabinoids in grocery stores and other retail locations will officially go into effect. Synthetic cannabinoids are derived from hemp and thus subject to much more limited regulations. The OLCC’s worries are not unfounded either.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

article thumbnail

CLE Webinar Hemp in Italy: Law, Research, and Industry Wednesday, July 28th, 11 a.m. PDT

Cannabis Law Report

We apply our entirely subjective bong score to each event. Featuring first-hand Italian experiences within the industry, the panelists will discuss; the discovery of new cannabinoids, the construction of the largest extraction plant in Europe, and will evaluate the European perspectives and the expected repercussions in Italy.

Hemp 105
article thumbnail

Tetra Bio-Pharma Files PCT Patent Application for Cannabis Plant Residue

Cannabis Law Report

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

article thumbnail

Devonian Health Group Announces Cannabis Cutting-Edge Extraction Equipment in Its Montmagny Facility

Cannabis Law Report

This agreement includes the installation of state-of-the-art ethanol extraction equipment in Devonian’s facility in Montmagny (Quebec) for the purpose of extracting cannabinoids from hemp and cannabis plant. Both parties expect to collaborate in the development of cannabinoid-based botanical drugs.

article thumbnail

Rep. Ford introduces Consumable Hemp Licensing bill

Illinois News Joint

In addition, HB4161 would: Permit the wholesale and retail sale of cannabinoids, hemp concentrate, or any other intermediate hemp cannabinoid products. Provide that hemp farms may not create hemp extractions without a processor license. Provide that hemp farms may not create hemp extractions without a processor license.

Hemp 105